Alzheimer's dementia (AD) is increasingly being recognized as one of the most important
medical and social problems in older people in industrialized and non-industrialized …

Dementia is characterized by the impairment of cognition and behavior of people over 65
years. Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder in the …

Background: The purpose of this review is to evaluate the data on the use of antipsychotics
in individuals with dementia from meta-analyses. Methods: We performed a literature search …

Objective We directly assessed the clinical trials' evidence for memantine's efficacy in mild
Alzheimer disease (AD). Memantine is indicated in the United States and Europe for …

Alzheimer's disease (AD) is a progressive and ultimately fatal condition that causes
debilitating memory loss and extensive deterioration of cognitive and functional abilities …

Neuropsychiatric symptoms of dementia (NPS) are a group of noncognitive symptoms that
occur in over 90% of individuals with dementia. NPS seem to result from a complex …

Background This is the first meta-analysis to compare the treatment effects and safety of
administering donepezil alone versus a combination of memantine and donepezil to treat …

Depression occurs with a high prevalence of up to 50% in patients with Alzheimer's disease
(AD) and increases the caregivers' burden. Depression symptoms can precede clinical …

Melatonin (MLT) is a neurohormone that is regulated by the circadian clock and plays
multifunctional roles in numerous neurodegenerative disorders, such as Alzheimer's …

We describe here three patients with the Alzheimer's Disease (AD) whose behavioral
symptoms were improved remarkably as a result of the turmeric treatment, which is the …